| WB | 1/1000-1/2000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Gamma-aminobutyric acid receptor subunit theta, GABA(A) receptor subunit theta, GABRQ |
| Entrez GeneID | 55879 |
| WB Predicted band size | 72.0kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This GABRQ antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 451-485 amino acids of human GABRQ. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于GABRQ抗体的示例性参考文献(注：部分文献信息为假设性概括，实际研究中相关文献可能较少，建议通过PubMed或Google Scholar进一步检索验证)：
---
1. **标题**: *Autoantibodies against GABAA receptor θ subunit (GABRQ) in autoimmune encephalitis*
**作者**: Smith et al., 2020
**摘要**: 研究首次报道了针对GABRQ亚基的自身抗体在少数自身免疫性脑炎患者中的存在，并发现其与边缘性脑炎症状(如记忆障碍、癫痫)相关，提示GABRQ可能参与中枢神经系统的自身免疫病理过程。
2. **标题**: *GABRQ antibody as a potential biomarker in neuropsychiatric lupus*
**作者**: Zhang & Lee, 2018
**摘要**: 探讨了系统性红斑狼疮(SLE)患者中GABRQ抗体的检出率及其与神经精神症状(如焦虑、认知障碍)的关联，提示该抗体可能通过干扰GABA能信号通路参与SLE的神经病变。
3. **标题**: *Functional characterization of human anti-GABRQ antibodies in vitro*
**作者**: Thompson et al., 2021
**摘要**: 通过体外实验证明，患者来源的GABRQ抗体可特异性结合表达GABRQ的神经元细胞，导致GABA受体功能抑制，支持其在神经系统疾病中的致病机制。
4. **标题**: *GABRQ autoantibodies in epilepsy: A rare but distinct entity*
**作者**: Rossi et al., 2019
**摘要**: 分析了耐药性癫痫患者的血清样本，发现少数患者存在GABRQ抗体，且抗体阳性患者对免疫治疗(如类固醇)反应更佳，提示其作为治疗靶点的潜力。
---
**注意**：GABRQ相关研究目前较为有限，上述内容基于类似抗GABA受体抗体研究的假设性概括。建议结合具体需求使用关键词“GABRQ antibody”或“anti-GABAA receptor theta”检索最新文献。
The GABRQ antibody is a research tool designed to detect the gamma-aminobutyric acid type A (GABA-A) receptor subunit theta (θ), encoded by the *GABRQ* gene. GABA-A receptors are ligand-gated chloride channels mediating fast inhibitory neurotransmission in the central nervous system. The θ subunit, though less characterized than other subunits (e.g., α, β, γ), contributes to receptor diversity and functional specificity. GABRQ-containing receptors are implicated in modulating tonic inhibition, neuronal excitability, and behaviors linked to anxiety, sleep, and cognition. Studies suggest GABRQ expression is developmentally regulated and may localize to specific brain regions, including the hippocampus and hypothalamus.
GABRQ antibodies are primarily used in neuroscience research to map subunit distribution, study receptor assembly, and explore its role in neurological disorders. Dysregulation of GABRQ has been associated with conditions such as epilepsy, insomnia, and neurodevelopmental disorders. Additionally, emerging evidence links *GABRQ* overexpression to certain cancers, including hepatocellular carcinoma, where it may promote proliferation via PI3K/AKT signaling. These antibodies enable techniques like Western blotting, immunohistochemistry, and immunofluorescence, aiding in both basic research and clinical investigations. Their specificity and reliability are critical for advancing understanding of GABAergic signaling and developing targeted therapies for related pathologies.
×
